✦ LIBER ✦
The benefits and risks of abciximab, eptifibatide, or tirofiban during PCI: Class effects or do they differ?
✍ Scribed by Felix Zijlstra
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 39 KB
- Volume
- 73
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.